Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040
Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 mill...
Saved in:
Published in | Thoracic cancer Vol. 14; no. 1; pp. 3 - 11 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Melbourne
John Wiley & Sons Australia, Ltd
01.01.2023
John Wiley & Sons, Inc Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 million deaths worldwide in 2020. Here, we present the global epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040 at different geographical levels of continents, regions and countries, and analyze them by gender, race, geographic region and human development index. We summarize the prospects for the esophageal cancer burden and risk factors in different areas, which will be useful for global esophageal cancer clinical therapy and cancer control planning.
Esophageal cancer is one of the most malignant cancers, with more than 0.6 million new cases of esophageal cancer and 0.54 million deaths worldwide in 2020. In current review, we present the global epidemiology of esophageal cancer in 2020 and projections to two decades later at different levels of continents, regions and countries and analyze them in gender, race, geographic region, and human development index. Graph showed global and top 3 countries with the highest incident cases of esophageal cancer in 2020 and projections to 2030 and 2040. |
---|---|
AbstractList | Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 million deaths worldwide in 2020. Here, we present the global epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040 at different geographical levels of continents, regions and countries, and analyze them by gender, race, geographic region and human development index. We summarize the prospects for the esophageal cancer burden and risk factors in different areas, which will be useful for global esophageal cancer clinical therapy and cancer control planning. Abstract Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 million deaths worldwide in 2020. Here, we present the global epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040 at different geographical levels of continents, regions and countries, and analyze them by gender, race, geographic region and human development index. We summarize the prospects for the esophageal cancer burden and risk factors in different areas, which will be useful for global esophageal cancer clinical therapy and cancer control planning. Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 million deaths worldwide in 2020. Here, we present the global epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040 at different geographical levels of continents, regions and countries, and analyze them by gender, race, geographic region and human development index. We summarize the prospects for the esophageal cancer burden and risk factors in different areas, which will be useful for global esophageal cancer clinical therapy and cancer control planning. Esophageal cancer is one of the most malignant cancers, with more than 0.6 million new cases of esophageal cancer and 0.54 million deaths worldwide in 2020. In current review, we present the global epidemiology of esophageal cancer in 2020 and projections to two decades later at different levels of continents, regions and countries and analyze them in gender, race, geographic region, and human development index. Graph abstract showed global and top 3 countries with the highest incident cases of esophageal cancer in 2020 and projections to 2030 and 2040. Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 million deaths worldwide in 2020. Here, we present the global epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040 at different geographical levels of continents, regions and countries, and analyze them by gender, race, geographic region and human development index. We summarize the prospects for the esophageal cancer burden and risk factors in different areas, which will be useful for global esophageal cancer clinical therapy and cancer control planning. Esophageal cancer is one of the most malignant cancers, with more than 0.6 million new cases of esophageal cancer and 0.54 million deaths worldwide in 2020. In current review, we present the global epidemiology of esophageal cancer in 2020 and projections to two decades later at different levels of continents, regions and countries and analyze them in gender, race, geographic region, and human development index. Graph showed global and top 3 countries with the highest incident cases of esophageal cancer in 2020 and projections to 2030 and 2040. Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 million deaths worldwide in 2020. Here, we present the global epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040 at different geographical levels of continents, regions and countries, and analyze them by gender, race, geographic region and human development index. We summarize the prospects for the esophageal cancer burden and risk factors in different areas, which will be useful for global esophageal cancer clinical therapy and cancer control planning. Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 million deaths worldwide in 2020. Here, we present the global epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040 at different geographical levels of continents, regions and countries, and analyze them by gender, race, geographic region and human development index. We summarize the prospects for the esophageal cancer burden and risk factors in different areas, which will be useful for global esophageal cancer clinical therapy and cancer control planning.Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 million deaths worldwide in 2020. Here, we present the global epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040 at different geographical levels of continents, regions and countries, and analyze them by gender, race, geographic region and human development index. We summarize the prospects for the esophageal cancer burden and risk factors in different areas, which will be useful for global esophageal cancer clinical therapy and cancer control planning. |
Author | Ma, Yun‐Lei Xu, Peng‐Fei Cui, Yong Qin, Qi Liu, Chun‐Quan Wang, Pei‐Hao Luo, Yi |
AuthorAffiliation | 3 Center for Pharmacogenetics and Department of Pharmaceutical Sciences University of Pittsburgh Pittsburgh Pennsylvania USA 2 School of Pharmaceutical Sciences Wuhan University Wuhan China 1 Department of Thoracic Surgery Beijing Friendship Hospital, Capital Medical University Beijing China |
AuthorAffiliation_xml | – name: 2 School of Pharmaceutical Sciences Wuhan University Wuhan China – name: 3 Center for Pharmacogenetics and Department of Pharmaceutical Sciences University of Pittsburgh Pittsburgh Pennsylvania USA – name: 1 Department of Thoracic Surgery Beijing Friendship Hospital, Capital Medical University Beijing China |
Author_xml | – sequence: 1 givenname: Chun‐Quan orcidid: 0000-0002-7075-3732 surname: Liu fullname: Liu, Chun‐Quan organization: Beijing Friendship Hospital, Capital Medical University – sequence: 2 givenname: Yun‐Lei surname: Ma fullname: Ma, Yun‐Lei organization: Beijing Friendship Hospital, Capital Medical University – sequence: 3 givenname: Qi surname: Qin fullname: Qin, Qi organization: Beijing Friendship Hospital, Capital Medical University – sequence: 4 givenname: Pei‐Hao surname: Wang fullname: Wang, Pei‐Hao organization: Beijing Friendship Hospital, Capital Medical University – sequence: 5 givenname: Yi surname: Luo fullname: Luo, Yi organization: Beijing Friendship Hospital, Capital Medical University – sequence: 6 givenname: Peng‐Fei orcidid: 0000-0001-6854-6040 surname: Xu fullname: Xu, Peng‐Fei email: pex9@pitt.edu, dyxufei@sina.com, dyxufei@sina.com organization: University of Pittsburgh – sequence: 7 givenname: Yong surname: Cui fullname: Cui, Yong email: cywork1@sina.com organization: Beijing Friendship Hospital, Capital Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36482832$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUk1vEzEQtVARLaFnbmglLlzS-tvrC1IVFSiqxKWcrVmvnTra2Iu9AeXf421KRHupDx5r_N7zeN68RScxRYfQe4IvSF2XRAm9VIrwC8IVF6_Q2TFzcjxjeYrOS9ngulirMRVv0CmTvKUto2fo-_UYercNaUjrfZN840oa72HtYGgsROtyE2JDMcUNxL4Zc9o4O4UUSzOlmmeHPMUcv0OvPQzFnT_GBfr55fpu9W15--PrzerqdmmF1mJJW0EVASJ6TWhLnAfuNfM9w1IBsQpk13pFpGPaa0tZx4V1NVjaSyUcYQt0c9DtE2zMmMMW8t4kCOYhkfLaQJ6CHZwBrKzi4DUQzSXvOt5iKz1mkjEq6r5Anw9a467but66OGUYnog-vYnh3qzTb6NbXFuOq8CnR4Gcfu1cmcw2FOuGAaJLu2KoEowRzOhc98dn0E3a5VhbVVGy2qMJmwU__F_RsZR_llXA5QFgcyolO3-EEGzmuTCz82aeAvMwF5UhnjFsmGA2sX4pDC_z_oTB7V96xtytrg68v-0ExTA |
CitedBy_id | crossref_primary_10_11569_wcjd_v32_i2_102 crossref_primary_10_1007_s00384_025_04849_2 crossref_primary_10_1016_j_jfma_2024_05_014 crossref_primary_10_1016_j_gassur_2025_101977 crossref_primary_10_1158_1055_9965_EPI_23_1343 crossref_primary_10_3390_diagnostics14131396 crossref_primary_10_1007_s12029_024_01159_8 crossref_primary_10_20517_2574_1225_2024_07 crossref_primary_10_1016_j_intimp_2024_112362 crossref_primary_10_1038_s41416_024_02683_x crossref_primary_10_1093_jrr_rrae041 crossref_primary_10_1007_s11864_025_01308_6 crossref_primary_10_1002_cam4_70212 crossref_primary_10_3390_medicina60111901 crossref_primary_10_1186_s43042_024_00564_9 crossref_primary_10_5604_01_3001_0054_9779 crossref_primary_10_4236_jbm_2025_133007 crossref_primary_10_1007_s12291_024_01219_7 crossref_primary_10_1186_s12893_024_02562_5 crossref_primary_10_3389_fonc_2023_1344328 crossref_primary_10_1016_j_lana_2024_100954 crossref_primary_10_1016_j_clon_2024_03_020 crossref_primary_10_1016_j_radcr_2024_10_072 crossref_primary_10_3389_fmed_2024_1356752 crossref_primary_10_1007_s10620_024_08375_z crossref_primary_10_3748_wjg_v30_i38_4168 crossref_primary_10_1016_j_gassur_2023_11_016 crossref_primary_10_1007_s11010_023_04913_x crossref_primary_10_1177_26345161231198626 crossref_primary_10_1002_cam4_6078 crossref_primary_10_21518_ms2024_527 crossref_primary_10_3748_wjg_v30_i11_1621 crossref_primary_10_7759_cureus_47835 crossref_primary_10_3390_jcm12227086 crossref_primary_10_1186_s12967_024_05825_0 crossref_primary_10_3892_or_2024_8860 crossref_primary_10_1016_j_cbi_2024_110875 crossref_primary_10_7326_M24_0377 crossref_primary_10_7759_cureus_79274 crossref_primary_10_4103_jmu_jmu_26_23 crossref_primary_10_1097_01_JAA_0001007328_84376_da crossref_primary_10_1016_j_ijscr_2024_110708 crossref_primary_10_1097_MS9_0000000000002674 crossref_primary_10_1172_JCI173649 crossref_primary_10_1111_jcmm_18294 crossref_primary_10_3390_cells14060411 crossref_primary_10_1093_dote_doae058 crossref_primary_10_1136_spcare_2024_005073 crossref_primary_10_3390_molecules29010230 crossref_primary_10_1016_j_soi_2024_100104 crossref_primary_10_1177_10732748241302957 crossref_primary_10_3390_bioengineering12010090 crossref_primary_10_14309_crj_0000000000001435 crossref_primary_10_5090_jcs_24_078 crossref_primary_10_1097_MD_0000000000040899 crossref_primary_10_2147_PPA_S472858 crossref_primary_10_1097_MD_0000000000038064 crossref_primary_10_12677_ACM_2023_13122646 crossref_primary_10_3390_cancers16020240 crossref_primary_10_36290_vnl_2023_108 crossref_primary_10_1016_j_humgen_2024_201312 crossref_primary_10_1016_j_biopha_2024_117368 crossref_primary_10_1016_j_prp_2024_155223 crossref_primary_10_3748_wjg_v30_i20_2638 crossref_primary_10_1007_s00464_024_10824_9 crossref_primary_10_3390_jcm14061845 crossref_primary_10_1016_j_mrgentox_2024_503766 crossref_primary_10_24884_0042_4625_2024_183_1_42_46 crossref_primary_10_3389_fgene_2024_1249751 crossref_primary_10_1097_COC_0000000000001147 crossref_primary_10_1016_j_ijbiomac_2024_133814 crossref_primary_10_1016_j_biopha_2024_117693 crossref_primary_10_3892_ijmm_2025_5503 crossref_primary_10_1016_j_heliyon_2023_e22654 crossref_primary_10_1007_s10388_024_01044_0 crossref_primary_10_1016_j_gassur_2024_07_004 crossref_primary_10_3390_cancers16081468 crossref_primary_10_3390_cancers16132460 crossref_primary_10_3904_kjim_2025_029 crossref_primary_10_3389_fonc_2023_1144516 crossref_primary_10_1016_j_ejphar_2025_177309 crossref_primary_10_1016_j_mtbio_2024_101394 crossref_primary_10_3390_cancers16234007 crossref_primary_10_3390_ijms25052691 crossref_primary_10_2147_DDDT_S476457 crossref_primary_10_1111_jgh_16689 crossref_primary_10_1371_journal_pone_0319854 crossref_primary_10_1016_j_athoracsur_2024_05_044 crossref_primary_10_3892_ijo_2025_5738 crossref_primary_10_1259_bjr_20220685 crossref_primary_10_1038_s41388_024_03123_z crossref_primary_10_1016_j_jss_2024_04_067 crossref_primary_10_1016_j_saa_2024_124461 crossref_primary_10_1016_j_asjsur_2024_04_149 crossref_primary_10_1002_hsr2_1342 crossref_primary_10_1016_j_ctro_2024_100817 crossref_primary_10_1093_dote_doae063 crossref_primary_10_1186_s12885_024_13151_3 crossref_primary_10_3389_fimmu_2023_1206504 crossref_primary_10_1186_s12911_023_02235_y crossref_primary_10_3390_cancers17071085 crossref_primary_10_4103_jfmpc_jfmpc_1150_24 crossref_primary_10_1053_j_gastro_2024_07_001 crossref_primary_10_1111_1759_7714_15246 crossref_primary_10_1002_ags3_12847 crossref_primary_10_1007_s00540_024_03432_3 crossref_primary_10_3390_cancers16030658 crossref_primary_10_4240_wjgs_v16_i5_1255 crossref_primary_10_1136_gutjnl_2024_333227 crossref_primary_10_1186_s12964_024_01475_3 crossref_primary_10_1007_s00210_025_03902_9 crossref_primary_10_1200_GO_24_00209 crossref_primary_10_58931_cot_2024_1220 crossref_primary_10_1515_iss_2023_0021 crossref_primary_10_1186_s40364_024_00718_2 crossref_primary_10_3904_kjim_2024_201 crossref_primary_10_1139_bcb_2023_0067 crossref_primary_10_1016_j_jtho_2023_12_021 crossref_primary_10_1016_j_ncrna_2023_05_009 crossref_primary_10_1016_j_jcmgh_2024_01_008 crossref_primary_10_3892_ol_2024_14406 crossref_primary_10_1016_j_humgen_2024_201355 crossref_primary_10_1097_MD_0000000000033895 crossref_primary_10_1007_s00261_024_04281_0 crossref_primary_10_4103_ATMR_ATMR_166_24 crossref_primary_10_1007_s10388_025_01112_z crossref_primary_10_1093_pubmed_fdae311 crossref_primary_10_1080_00365521_2024_2396479 crossref_primary_10_1002_ijc_34881 crossref_primary_10_1016_j_ijheh_2024_114466 crossref_primary_10_1016_j_canep_2023_102486 crossref_primary_10_1093_dote_doae086 crossref_primary_10_3389_fimmu_2024_1509051 crossref_primary_10_1007_s00761_024_01661_5 crossref_primary_10_1007_s00210_025_03861_1 crossref_primary_10_1016_j_wneu_2024_04_130 crossref_primary_10_1093_bjsopen_zrae054 crossref_primary_10_1097_JN9_0000000000000047 crossref_primary_10_1016_j_ejrad_2023_111263 crossref_primary_10_21294_1814_4861_2024_23_4_77_85 |
Cites_doi | 10.1080/14728222.2022.2036718 10.1186/s13045-020-00981-4 10.1007/s12032-010-9457-8 10.3748/wjg.v19.i34.5598 10.3748/wjg.v25.i31.4512 10.1038/bjc.2013.437 10.1245/s10434-011-2049-9 10.1093/annonc/mdn622 10.1016/S0140-6736(13)62224-2 10.3978/j.issn.2078-6891.2012.026 10.1016/j.canep.2016.02.001 10.1038/ajg.2017.155 10.1002/ijc.33285 10.1016/j.bbcan.2019.05.003 10.1159/000478863 10.3892/mco.2019.1843 10.1038/s41568-018-0024-5 10.1007/s00535-021-01815-x 10.1136/gutjnl-2014-308124 10.1053/j.gastro.2017.08.023 10.1053/j.gastro.2017.09.048 10.1016/S1470-2045(14)71123-4 10.1016/j.canep.2013.05.011 10.1016/S0140-6736(17)31462-9 10.1111/j.1442-2050.2006.00602.x 10.1007/s10552-014-0485-0 10.1093/jnci/djn211 10.4314/mmj.v27i3.3 10.1111/jgh.13289 10.1038/s41598-018-19819-8 10.1002/cncr.33119 10.3322/caac.21262 10.1016/j.dld.2018.08.002 10.1016/S2468-1253(20)30007-8 10.1002/ijc.30382 10.1056/NEJMoa1103042 10.1002/ijc.20616 10.1016/j.asjsur.2016.10.005 10.1002/ijc.20619 10.1007/s13277-014-2762-7 10.1186/s12957-020-02023-2 10.3978/j.issn.1000-9604.2015.01.06 10.1007/s12328-020-01237-x 10.1007/s10388-018-0641-9 10.1002/jso.25990 10.1371/journal.pone.0185778 10.1155/2019/1953497 |
ContentType | Journal Article |
Copyright | 2022 The Authors. published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. 2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2022 The Authors. published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. – notice: 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. – notice: 2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI 7X8 5PM DOA |
DOI | 10.1111/1759-7714.14745 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals (ODIN) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Liu et al |
EISSN | 1759-7714 |
EndPage | 11 |
ExternalDocumentID | oai_doaj_org_article_a07c74af9a19464bb480c6f036332536 PMC9807450 36482832 10_1111_1759_7714_14745 TCA14745 |
Genre | reviewArticle Research Support, Non-U.S. Gov't Journal Article Review |
GeographicLocations | Mongolia Malawi United States--US Asia Southern Africa China Africa Zimbabwe Central Asia |
GeographicLocations_xml | – name: Malawi – name: Asia – name: Zimbabwe – name: Central Asia – name: China – name: Mongolia – name: Africa – name: United States--US – name: Southern Africa |
GrantInformation_xml | – fundername: Wu Jieping Medical Foundation funderid: 320.6750.2022‐16‐16 – fundername: Capital Health Research and Development of Special Fund funderid: 2022‐2‐2024 – fundername: ; grantid: 320.6750.2022‐16‐16 – fundername: ; grantid: 2022‐2‐2024 |
GroupedDBID | --- 05W 0R~ 1OC 24P 31~ 4.4 50Y 53G 5VS 7X7 8-0 8-1 8FI 8FJ AAHHS AANHP AAWTL AAZKR ABDBF ABUWG ACBWZ ACCFJ ACCMX ACRPL ACUHS ACXQS ACYXJ ADBBV ADKYN ADNMO ADPDF ADZMN AEEZP AENEX AEQDE AFBPY AFKRA AHMBA AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AOIJS ASPBG AVUZU AVWKF AZFZN BCNDV BDRZF BENPR BPHCQ BVXVI CAG CCPQU COF D-A DIK EBD EBS EJD FEDTE FYUFA G-S GODZA GROUPED_DOAJ HMCUK HVGLF HYE HZ~ IAO IHR ITC KQ8 MY. MY~ O9- OK1 OVD PIMPY PQQKQ PROAC RPM RX1 SUPJJ TEORI UKHRP WIN AAYXX AGQPQ CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AAMMB AEFGJ AGXDD AIDQK AIDYY AZQEC DWQXO K9. PKEHL PQEST PQUKI 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c5995-285271a15d91281efa4f93fd3067a1c7a6b8f716e39f9c23b45ce23bc2d675e13 |
IEDL.DBID | 24P |
ISSN | 1759-7706 1759-7714 |
IngestDate | Wed Aug 27 01:30:22 EDT 2025 Thu Aug 21 18:38:15 EDT 2025 Thu Jul 10 22:02:20 EDT 2025 Fri Jul 25 07:45:12 EDT 2025 Wed Feb 19 02:24:50 EST 2025 Thu Apr 24 22:52:43 EDT 2025 Tue Jul 01 00:59:11 EDT 2025 Wed Jan 22 16:19:50 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | mortality esophageal cancer projection incidence |
Language | English |
License | Attribution-NonCommercial-NoDerivs 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5995-285271a15d91281efa4f93fd3067a1c7a6b8f716e39f9c23b45ce23bc2d675e13 |
Notes | Funding information Capital Health Research and Development of Special Fund, Grant/Award Number: 2022‐2‐2024; Wu Jieping Medical Foundation, Grant/Award Number: 320.6750.2022‐16‐16 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 Funding information Capital Health Research and Development of Special Fund, Grant/Award Number: 2022‐2‐2024; Wu Jieping Medical Foundation, Grant/Award Number: 320.6750.2022‐16‐16 |
ORCID | 0000-0002-7075-3732 0000-0001-6854-6040 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1111%2F1759-7714.14745 |
PMID | 36482832 |
PQID | 2760009130 |
PQPubID | 1006494 |
PageCount | 9 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_a07c74af9a19464bb480c6f036332536 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9807450 proquest_miscellaneous_2753310321 proquest_journals_2760009130 pubmed_primary_36482832 crossref_primary_10_1111_1759_7714_14745 crossref_citationtrail_10_1111_1759_7714_14745 wiley_primary_10_1111_1759_7714_14745_TCA14745 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | January 2023 |
PublicationDateYYYYMMDD | 2023-01-01 |
PublicationDate_xml | – month: 01 year: 2023 text: January 2023 |
PublicationDecade | 2020 |
PublicationPlace | Melbourne |
PublicationPlace_xml | – name: Melbourne – name: Singapore – name: Tianjin |
PublicationTitle | Thoracic cancer |
PublicationTitleAlternate | Thorac Cancer |
PublicationYear | 2023 |
Publisher | John Wiley & Sons Australia, Ltd John Wiley & Sons, Inc Wiley |
Publisher_xml | – name: John Wiley & Sons Australia, Ltd – name: John Wiley & Sons, Inc – name: Wiley |
References | 2017; 40 2015; 36 2019; 2019 2015; 16 2009; 20 2013; 109 2021; 148 2005; 113 2019; 10 2020; 126 2017; 390 2016; 31 2019; 16 2022; 26 2006; 19 2012; 19 2020; 13 2018; 41 2020; 122 2017; 112 2008; 100 2020; 18 2013; 19 2018; 18 2015; 26 2020; 5 2018; 154 2018; 8 2013; 37 2012; 3 2015; 27 2021; 56 2015; 64 2019; 25 2015; 65 2017; 12 2016; 41 2018 2016; 139 2018; 50 2011; 28 2014; 383 2019; 1872 2011; 365 e_1_2_8_28_1 e_1_2_8_29_1 Blot WJ (e_1_2_8_38_1) 2018 e_1_2_8_24_1 e_1_2_8_47_1 e_1_2_8_25_1 e_1_2_8_46_1 e_1_2_8_26_1 e_1_2_8_49_1 e_1_2_8_27_1 e_1_2_8_48_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_43_1 e_1_2_8_21_1 e_1_2_8_42_1 e_1_2_8_22_1 e_1_2_8_45_1 e_1_2_8_23_1 e_1_2_8_44_1 e_1_2_8_41_1 e_1_2_8_40_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_39_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_37_1 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_30_1 |
References_xml | – volume: 112 start-page: 1247 issue: 8 year: 2017 end-page: 55 article-title: Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030 publication-title: Am J Gastroenterol – volume: 148 start-page: 905 issue: 4 year: 2021 end-page: 13 article-title: Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma publication-title: Int J Cancer – volume: 3 start-page: 226 issue: 3 year: 2012 end-page: 31 article-title: The association between obesity factor and esophageal caner publication-title: J Gastrointest Oncol – volume: 13 start-page: 1010 issue: 6 year: 2020 end-page: 21 article-title: Epidemiology of esophageal cancer: update in global trends, etiology and risk factors publication-title: Clin J Gastroenterol – volume: 109 start-page: 1367 issue: 5 year: 2013 end-page: 72 article-title: Poor oral hygiene and risk of esophageal squamous cell carcinoma in Kashmir publication-title: Br J Cancer – volume: 113 start-page: 456 issue: 3 year: 2005 end-page: 63 article-title: Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China publication-title: Int J Cancer – start-page: 579 year: 2018 end-page: 93 – volume: 18 start-page: 549 issue: 9 year: 2018 end-page: 61 article-title: Deciphering the cells of origin of squamous cell carcinomas publication-title: Nat Rev Cancer – volume: 18 start-page: 252 issue: 1 year: 2020 article-title: Long‐term outcomes and safety of radical transmediastinal esophagectomy with preoperative docetaxel, cisplatin, and 5‐fluorouracil combination chemotherapy for locally advanced squamous cell carcinoma of the thoracic esophagus publication-title: World J Surg Oncol – volume: 19 start-page: 5598 issue: 34 year: 2013 end-page: 606 article-title: Epidemiology of esophageal cancer publication-title: World J Gastroenterol – volume: 27 start-page: 2 issue: 1 year: 2015 end-page: 12 article-title: Annual report on status of cancer in China, 2011 publication-title: Chin J Cancer Res – volume: 16 start-page: 1 issue: 1 year: 2019 end-page: 24 article-title: Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 1 publication-title: Esophagus – volume: 154 start-page: 360 issue: 2 year: 2018 end-page: 73 article-title: Epidemiology of esophageal squamous cell carcinoma publication-title: Gastroenterology – volume: 65 start-page: 87 issue: 2 year: 2015 end-page: 108 article-title: Global cancer statistics, 2012 publication-title: Ca‐Cancer J Clin – volume: 126 start-page: 4511 issue: 20 year: 2020 end-page: 20 article-title: Long‐term effectiveness of one‐time endoscopic screening for esophageal cancer: a community‐based study in rural China publication-title: Cancer – volume: 50 start-page: 991 issue: 10 year: 2018 end-page: 6 article-title: Prognostic factors in esophageal cancer treated with curative intent publication-title: Dig Liver Dis – volume: 19 start-page: 68 issue: 1 year: 2012 end-page: 74 article-title: A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5‐fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907) publication-title: Ann Surg Oncol – volume: 26 start-page: 159 issue: 1 year: 2015 end-page: 61 article-title: Incidence trend of esophageal squamous cell carcinoma: an analysis of surveillance epidemiology, and end results (SEER) database publication-title: Cancer Causes Control – volume: 25 start-page: 4512 issue: 31 year: 2019 end-page: 33 article-title: Systematic review and meta‐analysis of esophageal cancer in Africa: epidemiology, risk factors, management and outcomes publication-title: World J Gastroenterol – volume: 40 start-page: 417 issue: 7–8 year: 2017 end-page: 22 article-title: Circulating tumor cells in esophageal cancer publication-title: Oncol Res Treat – volume: 122 start-page: 412 issue: 3 year: 2020 end-page: 21 article-title: Should adenosquamous esophageal cancer be treated like adenocarcinoma or squamous cell carcinoma? publication-title: J Surg Oncol – volume: 365 start-page: 1375 issue: 15 year: 2011 end-page: 83 article-title: Incidence of adenocarcinoma among patients with Barrett's esophagus publication-title: N Engl J Med – volume: 16 start-page: 36 issue: 1 year: 2015 end-page: 46 article-title: Global burden of cancer attributable to high body‐mass index in 2012: a population‐based study publication-title: Lancet Oncol – volume: 390 start-page: 2383 issue: 10110 year: 2017 end-page: 96 article-title: Oesophageal cancer publication-title: Lancet – volume: 28 start-page: 188 issue: 1 year: 2011 end-page: 93 article-title: Relevance of serum estradiol and estrogen receptor beta expression from a high‐incidence area for esophageal squamous cell carcinoma in China publication-title: Med Oncol – volume: 56 start-page: 891 issue: 10 year: 2021 end-page: 902 article-title: Potential roles of gastroesophageal reflux in patients with superficial esophageal squamous cell carcinoma without major causative risk factors publication-title: J Gastroenterol – volume: 1872 start-page: 37 issue: 1 year: 2019 end-page: 48 article-title: From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma publication-title: Biochim Biophys Acta Rev Cancer – volume: 20 start-page: 231 issue: 2 year: 2009 end-page: 8 article-title: Histological type of esophageal cancer might affect response to neo‐adjuvant radiochemotherapy and subsequent prognosis publication-title: Ann Oncol – volume: 13 start-page: 146 issue: 1 year: 2020 article-title: Burden, trends, and risk factors of esophageal cancer in China from 1990 to 2017: an up‐to‐date overview and comparison with those in Japan and South Korea publication-title: J Hematol Oncol – volume: 36 start-page: 1627 issue: 3 year: 2015 end-page: 42 article-title: p16 hypermethylation: a biomarker for increased esophageal cancer susceptibility in high incidence region of North East India publication-title: Tumour Biol – volume: 37 start-page: 579 issue: 5 year: 2013 end-page: 84 article-title: Sex differences in the proportion of esophageal squamous cell carcinoma cases attributable to tobacco smoking and alcohol consumption publication-title: Cancer Epidemiol – volume: 12 issue: 10 year: 2017 article-title: The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: a nationwide population‐based cohort study of South Korea publication-title: PLoS One – volume: 41 start-page: 113 year: 2016 end-page: 21 article-title: Tobacco and alcohol as risk factors for oesophageal cancer in a high incidence area in South Africa publication-title: Cancer Epidemiol – volume: 27 start-page: 88 issue: 3 year: 2015 end-page: 92 article-title: Environmental risk factors for oesophageal cancer in Malawi: a case‐control study publication-title: Malawi Med J – volume: 41 start-page: 210 issue: 3 year: 2018 end-page: 5 article-title: Esophageal cancer: risk factors, genetic association, and treatment publication-title: Asian J Surg – volume: 2019 year: 2019 article-title: Systematic review with meta‐analysis: association of infection with esophageal cancer publication-title: Gastroenterol Res Pract – volume: 64 start-page: 381 issue: 3 year: 2015 end-page: 7 article-title: Global incidence of oesophageal cancer by histological subtype in 2012 publication-title: Gut – volume: 8 start-page: 4522 issue: 1 year: 2018 article-title: Global incidence and mortality of oesophageal cancer and their correlation with socioeconomic indicators temporal patterns and trends in 41 countries publication-title: Sci Rep – volume: 10 start-page: 575 issue: 6 year: 2019 end-page: 82 article-title: Clinical significance of preoperative chemoradiotherapy for advanced esophageal cancer, evaluated by propensity score matching and weighting of inverse probability of treatment. publication-title: Clin Oncol – volume: 5 start-page: 582 issue: 6 year: 2020 end-page: 97 article-title: The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990‐2017: a systematic analysis for the global burden of disease study 2017 publication-title: Lancet Gastroenterol Hepatol – volume: 139 start-page: 2436 issue: 11 year: 2016 end-page: 46 article-title: A global view on cancer incidence and national levels of the human development index publication-title: Int J Cancer – volume: 154 start-page: 437 issue: 2 year: 2018 end-page: 51 article-title: Management of patients with adenocarcinoma or squamous cancer of the esophagus publication-title: Gastroenterology – volume: 31 start-page: 1141 issue: 6 year: 2016 end-page: 6 article-title: Trends in esophageal cancer survival in United States adults from 1973 to 2009: a SEER database analysis publication-title: J Gastroenterol Hepatol – volume: 113 start-page: 475 issue: 3 year: 2005 end-page: 82 article-title: Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan publication-title: Int J Cancer – volume: 100 start-page: 1184 issue: 16 year: 2008 end-page: 7 article-title: Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age publication-title: J Natl Cancer Inst – volume: 19 start-page: 321 issue: 5 year: 2006 end-page: 8 article-title: Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma publication-title: Dis Esophagus – volume: 383 start-page: 549 issue: 9916 year: 2014 end-page: 57 article-title: Global cancer patterns: causes and prevention publication-title: Lancet – volume: 26 start-page: 107 issue: 2 year: 2022 end-page: 17 article-title: Esophageal cancer: emerging therapeutics publication-title: Expert Opin Ther Targets – ident: e_1_2_8_8_1 doi: 10.1080/14728222.2022.2036718 – ident: e_1_2_8_10_1 doi: 10.1186/s13045-020-00981-4 – ident: e_1_2_8_23_1 doi: 10.1007/s12032-010-9457-8 – ident: e_1_2_8_6_1 doi: 10.3748/wjg.v19.i34.5598 – ident: e_1_2_8_4_1 doi: 10.3748/wjg.v25.i31.4512 – ident: e_1_2_8_31_1 doi: 10.1038/bjc.2013.437 – ident: e_1_2_8_45_1 doi: 10.1245/s10434-011-2049-9 – ident: e_1_2_8_43_1 doi: 10.1093/annonc/mdn622 – ident: e_1_2_8_48_1 doi: 10.1016/S0140-6736(13)62224-2 – ident: e_1_2_8_25_1 doi: 10.3978/j.issn.2078-6891.2012.026 – ident: e_1_2_8_26_1 doi: 10.1016/j.canep.2016.02.001 – ident: e_1_2_8_14_1 doi: 10.1038/ajg.2017.155 – ident: e_1_2_8_24_1 doi: 10.1002/ijc.33285 – ident: e_1_2_8_13_1 doi: 10.1016/j.bbcan.2019.05.003 – ident: e_1_2_8_20_1 doi: 10.1159/000478863 – ident: e_1_2_8_47_1 doi: 10.3892/mco.2019.1843 – ident: e_1_2_8_9_1 doi: 10.1038/s41568-018-0024-5 – ident: e_1_2_8_39_1 doi: 10.1007/s00535-021-01815-x – ident: e_1_2_8_7_1 doi: 10.1136/gutjnl-2014-308124 – ident: e_1_2_8_12_1 doi: 10.1053/j.gastro.2017.08.023 – ident: e_1_2_8_18_1 doi: 10.1053/j.gastro.2017.09.048 – ident: e_1_2_8_36_1 doi: 10.1016/S1470-2045(14)71123-4 – ident: e_1_2_8_32_1 doi: 10.1016/j.canep.2013.05.011 – ident: e_1_2_8_2_1 doi: 10.1016/S0140-6736(17)31462-9 – ident: e_1_2_8_17_1 doi: 10.1111/j.1442-2050.2006.00602.x – ident: e_1_2_8_40_1 doi: 10.1007/s10552-014-0485-0 – ident: e_1_2_8_41_1 doi: 10.1093/jnci/djn211 – ident: e_1_2_8_29_1 doi: 10.4314/mmj.v27i3.3 – ident: e_1_2_8_19_1 doi: 10.1111/jgh.13289 – ident: e_1_2_8_16_1 doi: 10.1038/s41598-018-19819-8 – ident: e_1_2_8_49_1 doi: 10.1002/cncr.33119 – ident: e_1_2_8_11_1 doi: 10.3322/caac.21262 – ident: e_1_2_8_44_1 doi: 10.1016/j.dld.2018.08.002 – ident: e_1_2_8_3_1 doi: 10.1016/S2468-1253(20)30007-8 – ident: e_1_2_8_15_1 doi: 10.1002/ijc.30382 – ident: e_1_2_8_35_1 doi: 10.1056/NEJMoa1103042 – start-page: 579 volume-title: Cancer Epidemiology and Prevention year: 2018 ident: e_1_2_8_38_1 – ident: e_1_2_8_30_1 doi: 10.1002/ijc.20616 – ident: e_1_2_8_21_1 doi: 10.1016/j.asjsur.2016.10.005 – ident: e_1_2_8_34_1 doi: 10.1002/ijc.20619 – ident: e_1_2_8_33_1 doi: 10.1007/s13277-014-2762-7 – ident: e_1_2_8_46_1 doi: 10.1186/s12957-020-02023-2 – ident: e_1_2_8_27_1 doi: 10.3978/j.issn.1000-9604.2015.01.06 – ident: e_1_2_8_5_1 doi: 10.1007/s12328-020-01237-x – ident: e_1_2_8_28_1 doi: 10.1007/s10388-018-0641-9 – ident: e_1_2_8_42_1 doi: 10.1002/jso.25990 – ident: e_1_2_8_22_1 doi: 10.1371/journal.pone.0185778 – ident: e_1_2_8_37_1 doi: 10.1155/2019/1953497 |
SSID | ssj0000389025 |
Score | 2.620096 |
SecondaryResourceType | review_article |
Snippet | Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from... Abstract Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths... |
SourceID | doaj pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 3 |
SubjectTerms | African Americans Age Epidemiology Esophageal cancer Esophageal Neoplasms - epidemiology Human Development Index Humans Incidence Mortality Population Prognosis projection Regions Review Risk Factors |
SummonAdditionalLinks | – databaseName: DOAJ Open Access Full Text dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NSx0xEB-Kh9KLaGvrVltS8NDL6m6S_cjRio-HYE8K3kI-UZB9os9D_3tnsnnP97DixdMuSZYNk0nmN5nkNwAH3lq0SojcXBdkKb3ipUHDXHpneGUdOiGRLief_22nl_LsqrlaSfVFZ8JGeuBRcEem6lwnTVQG3e1WWiv7yrWR4o-CNyKRbaPNW3Gm0hosUvws3YZsFELIqs28PnSMJ5fVEteJji4yrZikxNz_P7j58tTkKppN5miyBZsZR7Ljsf_b8CEMn-HjeY6Uf4Gz0-fUr__YLLJA-Qpw8cCPHI30PbsZGEcYx8zgWd6QIR1k8xmWi7Gc4-zbgcvJ6cXJtMx5E0pH9GEl7xve1aZuvKI4WYhGRiWiJ-_A1K4zre0j-klBqKgcF1Y2LuDDcY_uQ6jFV9gYZkPYBeY7i4hPeS-VlV4a27eV8dI6oayTLhRwuBCddplUnHJb3OqFc0Gy1iRrnWRdwO_lB3cjn8brTf_QWCybERF2KkD10Fk99FvqUcD-YiR1np0PmlM0kghRqwJ-LatxXlGwxAxh9khtEAgT22BdwLdx4Jc9Ea3sKcVTAd2aSqx1db1muLlO3N2KyIca_O9hUp63ZKAvTo7Ty_f3EMYefEK9EuMO0j5szO8fww_EVHP7M02fJ4fME70 priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Ja90wEB7aFEovId3dpEWFHnpxakuyZZ1KGhJCID0l8G5Cm9tAsdOXl0P-fWdkPSePbicbWcb2LJpN_gbgQ3AOrRJ6bl5FWcqgeWnRMJfBW145j0FITz8nn31tTy7k6aJZ5ITbdd5WuV4T00IdRk858k-cKkgEYll9vvpZUtcoqq7mFhoP4RFBl9GWLrVQc46FwOOq1HcVjaRGR7JqM7oPbebJY7XE1ULR70z3DFPC7_-T0_n73sn7Pm0ySsc7sJ29SXYwsf8pPIjDM3h8luvlz-H06K4B7C0bexapawEuIXiTJ34v2eXAODpzzA6B5bQMSSJbjTgupnGOOvgCLo6Pzg9Pytw9ofQEIlbyruGqtnUTNFXLYm9lr0UfKEawtVe2dV2P0VIUuteeCycbH_HgecAgItbiJWwN4xBfAwvKod-nQ5DaySCt69rKBum80M5LHwvYX5PO-AwtTh0ufph1iEG0NkRrk2hdwMf5hqsJVePvU78QL-ZpBIedBsblN5O1y9hKeSVtr22tZSudk13l256K1II3oi1gb81Jk3X02txJVAHv58uoXVQysUMcb2gOusOEOVgX8Gpi_PwmopUdNXoqQG2IxMarbl4ZLr8nBG9NEEQNPnc_Cc__aGDODw_SyZt_f8cuPEGJEVOGaA-2Vsub-BZ9ppV7lxTjF4EpDDY priority: 102 providerName: ProQuest |
Title | Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040 |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2F1759-7714.14745 https://www.ncbi.nlm.nih.gov/pubmed/36482832 https://www.proquest.com/docview/2760009130 https://www.proquest.com/docview/2753310321 https://pubmed.ncbi.nlm.nih.gov/PMC9807450 https://doaj.org/article/a07c74af9a19464bb480c6f036332536 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB7aBEovpe-6TRcVeujFxZZkyzomYUMIJISSQG5GzzZQ7LLZHPrvOyNr3WwflF5sI0u2Gc14XtI3AO-9taiV0HJzKshSes1Lg4q59M7wyjp0QiJtTj49a48v5clVs1lNSHthJnyIOeBGkpH-1yTgxt7cEXLUexptw1qisCvZ3Idd2mBL8Plcns9hFsKPq1Lp1dy_ajPAD63n-eUZW7opQfj_ye78ffnkXbM26aWjx_AoG5Rsf-KAJ3AvDE_hwWlOmT-Dk-XPGrDf2RhZoMIF-BfBQY6mfMWuB8bRnmNm8CxHZogZ2XrEdjG1cxTD53B5tLw4PC5zAYXSEY5YybuGq9rUjdeUMAvRyKhF9OQmmNop09ouosMUhI7acWFl4wKeHPfoR4RavICdYRzCK2BeWTT9tPdSW-mlsV1bGS-tE9o66UIBHzek611GF6ciF1_7jZdBtO6J1n2idQEf5gHfJmCNv3c9oLmYuxEidmoYV5_7LGC9qZRT0kRtao1sYK3sKtdGylML3oi2gL3NTPZZTG96TmlJQkatCng330YBo6yJGcJ4S33QIibYwbqAl9PEz18iWtlRracC1BZLbH3q9p3h-ksC8daEQtTgeycm_xcN-ovD_XTx-n8HvIGHyENiChvtwc56dRveoiG1toskKnhUV2oBuwfLs_NPixSU-AHiFxE_ |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVIJeEG8MBYwEEhcXe3f92ANCbUmVPhIhlEq9ufsyrYTskqZC_VP8RmbsddqI16mnROt17MzO7Hyzs_sNwBurNXolRG4mdyISVrJIoWOOrFEs1gaDkIoOJ48n2ehQ7B2lRyvwsz8LQ9sq-zmxnahtY2iN_D2jDBKRWMYfz75HVDWKsqt9CY1OLfbd5Q8M2c4_7H7C8X3L2M5wuj2KfFWByBC5VsSKlOWJSlIrKYvkKiUqyStL2FklJleZLiqMIhyXlTSMa5Eahx-GWQTXLuH4u7dgVXAMZQawujWcfP6yWNUhurq4rfSKblkidI0zzydE24d8WyJwfsrpANU1V9hWDPgTzP19t-Z1FN26wZ17cNfj13CzU7j7sOLqB3B77DP0D2FveFVy9jJsqtBRnQSctPAmQxo2C0_rkCF8DFVtQ78QRLofzhts5107Q6t_BIc3ItnHMKib2j2F0OYakaa0VkgtrFC6yGJlhTZcaiOMC2CjF11pPJk51dT4VvZBDcm6JFmXrawDeLe44azj8fh71y0ai0U3IuBuG5rZ19Lbc6ni3ORCVVIlUmRCa1HEJqsoLc5ZyrMA1vuRLP2scF5e6XAArxeX0Z4pSaNq11xQHwTgxHKYBPCkG_jFm_BMFFRaKoB8SSWWXnX5Sn160nKGSyI9SvG5G63y_E8G5XR7s_3y7N__4xXcGU3HB-XB7mT_Oayh9vBufWodBvPZhXuBiG2uX3ozCeH4pi3zF3OxSXs |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlVcEO8GCgQJJC5pE9uJ4wNCpe2qD1pxaKW9Bb8ClVBStluh_jV-HTOJk3bF69TTrhxnkx3P47PH_gbgtTMGoxIiNyu9SIRTLNEYmBNnNUuNxUlITYeTD4-K3ROxP82nS_BzOAtD2yoHn9g5atdaWiPfYJRBIhLLdKMO2yI-bU_en31PqIIUZVqHchq9ihz4yx84fTt_t7eNY_2GscnO8dZuEioMJJaIthJW5kxmOsudooySr7WoFa8d4WidWakLU9Y4o_Bc1coybkRuPX5Y5hBo-4zj796C25LnGdmYnMpxfYeI69Ku5isGaIUgNi0CsxBtJAptmUBPJeko1bWg2NUO-BPg_X3f5nU83QXEyT24G5BsvNmr3n1Y8s0DWDkMufqHsL9zVXz2Mm7r2FPFBHRfeJMlXZvFp03MEEjGunFxWBIiK4jnLbbzvp2h_T-CkxuR62NYbtrGr0LspEHMqZwTyggntCmLVDthLFfGCusjWB9EV9lAa07VNb5Vw_SGZF2RrKtO1hG8HW846xk9_t71A43F2I2ouLuGdvalCpZd6VRaKXStdKZEIYwRZWqLmhLknOW8iGBtGMkq-Ifz6kqbI3g1XkbLpnSNbnx7QX0QihPfYRbBk37gxzfhhSipyFQEckElFl518Upz-rVjD1dEf5Tjc9c75fmfDKrjrc3uy9N__4-XsIL2WH3cOzp4BndQeXi_ULUGy_PZhX-O0G1uXnQ2EsPnmzbKX5lRTEs |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epidemiology+of+esophageal+cancer+in+2020+and+projections+to+2030+and+2040&rft.jtitle=Thoracic+cancer&rft.au=Liu%2C+Chun%E2%80%90Quan&rft.au=Ma%2C+Yun%E2%80%90Lei&rft.au=Qin%2C+Qi&rft.au=Wang%2C+Pei%E2%80%90Hao&rft.date=2023-01-01&rft.pub=John+Wiley+%26+Sons+Australia%2C+Ltd&rft.issn=1759-7706&rft.eissn=1759-7714&rft.volume=14&rft.issue=1&rft.spage=3&rft.epage=11&rft_id=info:doi/10.1111%2F1759-7714.14745&rft.externalDBID=10.1111%252F1759-7714.14745&rft.externalDocID=TCA14745 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1759-7706&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1759-7706&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1759-7706&client=summon |